Preprint · OA
via OpenAlex
Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease
Manuchair Ebadi, Holly M. Brown‐Borg, Hesham El Refaey, Brij Bhan Singh, Scott H. Garrett, Shavali Shaik, Sushil Kumar Sharma
Molecular Brain Research · 2004 · ▲ 108 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.molbrainres.2004.09.011
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Ebadi, M., Brown‐Borg, H.M., Refaey, H.E., Singh, B.B., Garrett, S.H., Shaik, S., & Sharma, S.K. (2004). Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease. <em>Molecular Brain Research</em>. https://doi.org/10.1016/j.molbrainres.2004.09.011
Vancouver
Ebadi M, Brown‐Borg HM, Refaey HE, Singh BB, Garrett SH, Shaik S, et al. Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease. Molecular Brain Research. 2004. doi:10.1016/j.molbrainres.2004.09.011.
BibTeX
@unpublished{manuchair2004Metall,
title = {Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease},
author = {Manuchair Ebadi and Holly M. Brown‐Borg and Hesham El Refaey and Brij Bhan Singh and Scott H. Garrett and Shavali Shaik and Sushil Kumar Sharma},
journal = {Molecular Brain Research},
year = {2004},
doi = {10.1016/j.molbrainres.2004.09.011},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Lancet 2009
Citation only
Parkinson's disease
The Lancet 2021
Open access · OA
Parkinson's disease
Neurobiology of Disease 2014
Preprint · CC-BY
Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson's disease
DigitalGeorgetown (Georgetown University Library) 2012
Preprint · OA
Alpha-synuclein and the multiple hit hypothesis of Parkinson's disease
Molecular Neurobiology 2023
Preprint · OA
CMS121 Partially Attenuates Disease Progression in Mouse Models of Huntington’s Disease
The Lancet 2024
Preprint · CC-BY